Skip to main content
. 2019 Feb 4;10(2):99. doi: 10.1038/s41419-019-1371-1

Table 1.

Correlation between the expression of CHD1L and therapy response in NSCLC patients (N = 30)

CHD1L expression level
Cases Normal expression Overexpression P value
Chemotherapy response
  NC + PD 18 5 (27.8%) 13(72.2%)
  PR 12 9 (75.0%) 3 (25.0%) P < 0.05

NC no change, PD progressive disease, PR partial response